Clinical Trials Logo

Methamphetamine Abuse clinical trials

View clinical trials related to Methamphetamine Abuse.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04883021 Withdrawn - Clinical trials for Methamphetamine Abuse

A Pilot Study of Repetitive Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

We propose a single-arm clinical trial, with historical controls as a comparison group for select outcomes. Subjects with MAUD will receive 16 sessions of dual-target theta burst stimulation to the DLPFC and MPFC over 4 weeks. We will follow outcomes for 12 weeks. Outcomes include treatment retention, craving, self-reported MA or stimulant use, urine drug screen results, depressive symptoms, anxiety symptoms, sleep quality, quality of life, response inhibition, and functional connectivity. Magnetic resonance imaging (MRI) to measure functional connectivity at baseline and four weeks.

NCT ID: NCT01601717 Withdrawn - Substance Abuse Clinical Trials

RTI-336 as a Treatment for Methamphetamine Dependence

Start date: January 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of RTI-336 as a treatment for methamphetamine (METH) dependence in non-treatment-seeking METH-dependent volunteers.

NCT ID: NCT00733967 Withdrawn - Substance Abuse Clinical Trials

Varenicline-Methamphetamine Interaction Study (2008)

Start date: January 2008
Phase: Phase 1
Study type: Interventional

The primary aim of the study is to determine the safety and tolerability of treatment with Varenicline in methamphetamine-dependent volunteers. The investigators also seek to determine the effects of treatment with Varenicline, as compared to placebo, on craving for methamphetamine or cigarettes following exposure to methamphetamine and smoking cues, respectively. The effects of treatment with Varenicline, as compared to placebo, on subjective effects produced by administration of methamphetamine or placebo will be attempted to be determined. Lastly, the investigators hope to determine the effects of treatment with Varenicline, as compared to placebo, on reinforcing effects produced by administration of methamphetamine or placebo.